Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Immutep Ltd ADR stock

Learn how to easily invest in Immutep Ltd ADR stock.

Immutep Ltd ADR is a biotechnology business based in the US. Immutep Ltd ADR shares (IMMP) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Immutep Ltd ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IMMP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Immutep Ltd ADR stock price (NASDAQ: IMMP)

Use our graph to track the performance of IMMP stocks over time.

Immutep Ltd ADR shares at a glance

Information last updated 2022-09-26.
Latest market close$1.71
52-week range$1.64 - $5.00
50-day moving average $2.06
200-day moving average $2.54
Wall St. target price$7.98
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.24

Buy Immutep Ltd ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Immutep Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Immutep Ltd ADR price performance over time

Historical closes compared with the close of $1.71 from 2022-09-23

1 week (2022-09-20) -3.39%
1 month (2022-08-26) -15.35%
3 months (2022-06-27) -20.09%
6 months (2022-03-23) N/A
1 year (2021-09-23) -56.82%
2 years (2020-09-25) 1.71
3 years (2019-09-27) 6.87%
5 years (2017-09-27) 2.40%

Immutep Ltd ADR financials

Revenue TTM $4.7 million
Gross profit TTM $-26,627,215
Return on assets TTM -22.96%
Return on equity TTM -38.49%
Profit margin 0%
Book value $1.09
Market capitalisation $149.6 million

TTM: trailing 12 months

Immutep Ltd ADR share dividends

We're not expecting Immutep Ltd ADR to pay a dividend over the next 12 months.

Have Immutep Ltd ADR's shares ever split?

Immutep Ltd ADR's shares were split on a 3:10 basis on 27 December 2016. So if you had owned 10 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Immutep Ltd ADR shares – just the quantity. However, indirectly, the new 233.3% higher share price could have impacted the market appetite for Immutep Ltd ADR shares which in turn could have impacted Immutep Ltd ADR's share price.

Immutep Ltd ADR share price volatility

Over the last 12 months, Immutep Ltd ADR's shares have ranged in value from as little as $1.64 up to $5. A popular way to gauge a stock's volatility is its "beta".

IMMP.US volatility(beta: 1.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immutep Ltd ADR's is 1.9323. This would suggest that Immutep Ltd ADR's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Immutep Ltd ADR overview

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemo-immunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-003, which is in a Phase I clinical trial for the treatment of solid tumors, as well as INSIGHT-005 that is in Phase I/IIa clinical trial to treat solid tumors. In addition, it offers IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. Immutep Limited has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc. , Merck & Co.

Frequently asked questions

What percentage of Immutep Ltd ADR is owned by institutions?
Currently 11.522% of Immutep Ltd ADR shares are held by institutions.
When does the fiscal year end for Immutep Ltd ADR?
Immutep Ltd ADR's fiscal year ends in June.
Where is Immutep Ltd ADR based?
Immutep Ltd ADR's address is: Australia Square, Sydney, NSW, Australia, 2000
What is Immutep Ltd ADR's ISIN number?
Immutep Ltd ADR's international securities identification number is: US45257L1089
What is Immutep Ltd ADR's CUSIP number?
Immutep Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 45257L108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site